Sign in to view content

Episode 2: Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration with Dr. Brian Ballio

Keyvan Koushan, MD, FRCSC

Audio
Published 2017

Related

PRN cycles of three monthly anti-VEGF injections in neovascular AMD: 12 and 24 months results.
Touka Banaee, MD
On Demand Cases, Courses, and Papers
2019
Fluctuations in Central Foveal Thickness and Vision Outcomes With AntiVEGF Therapy for Neovascular Age-Related Macular Degeneration
Veeral S. Sheth, MD, MBA, FASRS, FACS
Updates from the Field
2020
Does Anti-VEGF Therapy Affect the Rate of Expansion of Geographic Atrophy in Patients with Neovascular AMD Managed by a Treat-Extend-Stop Protocol?
Sean David Adrean, MD, FAAO, FASRS
On Demand Cases, Courses, and Papers
2019

Category: AMD-Neovascular

See more